NEJM -- Peginterferon Alfa-2a plus Ribavirin for (Hep C Chronic Fatigue)
NEJM -- Peginterferon Alfa-2a plus Ribavirin for
Peginterferon Alfa-2a plus Ribavirin for
Moving right along, I'll up-date the progression with my
Saturday, December 17, 2005
NEJM -- Peginterferon Alfa-2a plus Ribavirin for
Peginterferon Alfa-2a plus Ribavirin for
Moving right along, I'll up-date the progression with my
A Summary of Chronic Hepatitis C InfectionHepatitis C is a (Hep C Chronic Fatigue)
A Summary of Chronic Hepatitis C Infection
Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.
Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.
Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.
The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.
Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.
Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.
Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.
Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.
About the Author
Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.
Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.
Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.
Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.
The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.
Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.
Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.
Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.
Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.
About the Author
Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.
A Summary of Chronic Hepatitis C InfectionHepatitis C is a (Hep C Chronic Fatigue)
A Summary of Chronic Hepatitis C Infection
Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.
Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.
Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.
The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.
Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.
Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.
Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.
Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.
About the Author
Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.
Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.
Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.
Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.
The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.
Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.
Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.
Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.
Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.
About the Author
Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.
EU scientists seek big investment in nanomedicine (Hep C Chronic Fatigue)
EU scientists seek big investment in nanomedicine
ABCNEWS.com - to carry tumor-killing agents into cells, while
Phase III Trial Shows Zadaxin Ineffective for Treatment of
HIV and Hepatitis.com - Health Medical ViroLogic Incorporated Top Articles This Week Phase III Trial Shows Zadaxin Ineffective for Treatment of
Aethlon Medical (AEMD) Provides Progress Report To Wall Street
BioSpace - This is a small safety study of
Friday, December 16, 2005
winner.com.ru - Viral Hepatitis B - types topic treatment who releases (Hep C Chronic Fatigue)
winner.com.ru - Viral Hepatitis B - types topic treatment who releases
viral heaptitis b , viral hepatitiks b , vural hepatitis b , virl hepatitis b , viral hepatitgis b , viral hepaftitis b , viral hdpatitis b , virql hepatitis b , viral hepatirtis b , viral hepa6titis b , viral
ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE
Thursday, December 15, 2005
Albuferon-Alpha (Albumin-Interferon Alpha) (Hep C Chronic Fatigue)
Albuferon-Alpha (Albumin-Interferon Alpha)
National AIDS Treatment Advocacy Project - Albuferon as a potential treatment for chronic hepatitis C. Clinical and preclinical results to date development for the treatment of chronic hepatitis C. Phase 2 Study in
A Summary of Chronic Hepatitis C InfectionHepatitis C is a (Hep C Chronic Fatigue)
A Summary of Chronic Hepatitis C Infection
Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.
Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.
Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.
The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.
Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.
Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.
Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.
Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.
About the Author
Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.
Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.
Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.
Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.
The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.
Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.
Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.
Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.
Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.
About the Author
Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.
Migenix initiates phase II trial of hepatitis C treatment (Hep C Chronic Fatigue)
Migenix initiates phase II trial of hepatitis C treatment
Datamonitor - With the large market potential and unmet need in current hepatitis C treatment, Celgosivir is an important component of our value proposition in the short-term. first-in-class alpha glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis C virus infections
Patients with Hepatitis C using more healthcare resources
EurekAlert! - Hepatology is available online via Wiley InterScience Chronic Hepatitis C virus (HCV) affects about 3 million people
Positive phase I trial for Schering-Plough HCV treatment
Datamonitor - Currently, there are no products approved for treating HCV patients who failed previous therapies, representing an area of great unmet medical need. representing an area of great unmet medical need. Chronic hepatitis C affects more than 10 million people in major world
Hepatitis C in the Yahoo! Directory (Hep C Chronic Fatigue)
Hepatitis C in the Yahoo! Directory
CDC: Viral Hepatitis C - includes information on prevention, testing, and risk factors, and management of HCV infection. Hep C Connection - Hepatitis C
eMedicine - Hepatitis, Viral : Article by David C Wolf, MD, FACP, FACG
Poynard T, Leroy V, Cohard M, et al: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Viral Hepatitis C
Hepatitis C and Complementary and Alternative Medicine: 2003 Update
The authors concluded "glycyrrhizin is a potential drug in reducing long-term complications in chronic viral hepatitis C in patients who do not respond with
Hepatitis, Viral
Management of viral hepatitis C. J Gastroenterol Hepatol. 2002;17 Suppl: S146-S154. Liaw YF, Leung NW, Chang TT, et al. Effects of extended lamivudine
Wednesday, December 14, 2005
Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic (Hep C Chronic Fatigue)
Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)
Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)
ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN
Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China
Research Method:
Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.
Number of cases: 25 (n)
Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.
Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.
Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.
Observation index:
- HBV-DNA response after the treatment.
- Lasting HBV-DNA response (six months after withdrawal).
p>
Criterion of Therapeutic Effect:
- If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
- Lasting response:
HBV-DNA volume 1 104 cp/mL: 2/25 (8%)
Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it
Conclusion
The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.
Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.
* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.
For more information, please visit: http://www.vigconic.com
Or, contact:
William Yip cs@vigconic.com
5/F, Cheung Wah Building, Sheung Heung Rd,
Kowloon, Hong Kong
Tel: 852-27656200
Fax: 852-27645314
Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China
2002 national guideline on the management of the viral hepatitides A, B, and C. (Hep C Chronic Fatigue)
2002 national guideline on the management of the viral hepatitides A, B, and C.
... Assessment/Diagnosis of Viral Hepatitis C ... Management/Treatment of Viral Hepatitis C ...
Hepatitis C Surveillance Protocol
... Public Health Surveillance for Acute Viral Hepatitis C Flowchart ... Case Definition for Viral Hepatitis C Infection (past or present) ...
Hepatitis non-B, non-C - Test for Viral Hepatitis
REFERENCES - Tests for Viral Hepatitis. 1. ... Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update ...
dr dre the chronic cellulitis mrsa cellulitis hand (Hep C Chronic Fatigue)
dr dre the chronic cellulitis mrsa cellulitis hand
... London, England. hep c/chronic fatigue/fibromyalgia/long-term dis ...
Blogger: Recently Updated Blogs
... 06:40:10 AM Hep C Chronic Fatigue. 06:40:11 AM Kimberly Lacey ...
Opc3 - " ! #" $% & ' !(0)0 10 32425 6)0( 798 ) (0( 5
... medicine pressly baby walking shoes french language hepititus seguros de coches hep c chronic fatigue syndrome bawd ...
Tuesday, December 13, 2005
Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is (Hep C Chronic Fatigue)
Ways You Can Get Infected With Hepatitis C
(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:
(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:
Sharing needles, straws, pipes, spoons and other drug-related equipment.
(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus)
Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques
Being born to a mother with hepatitis C
Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.)
People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.
It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.
If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.
About The Author
News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.
News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.
Hepatitis C Top Articles (Hep C Chronic Fatigue)
Hepatitis C Top Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines for chronic hepatitis B.
Tattooing Is a Major Route of Hepatitis C Infection, Says Researcher
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and experimental vaccines for Hepatitis C.
HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates
Featuring the latest news about Hepatitis C infection, Hepatitis C diagnosis, Hepatitis C symptoms, and Hepatitis C treatments.
Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic (Hep C Chronic Fatigue)
Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)
Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)
ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN
Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China
Research Method:
Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.
Number of cases: 25 (n)
Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.
Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.
Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.
Observation index:
- HBV-DNA response after the treatment.
- Lasting HBV-DNA response (six months after withdrawal).
p>
Criterion of Therapeutic Effect:
- If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
- Lasting response:
HBV-DNA volume 1 104 cp/mL: 2/25 (8%)
Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it
Conclusion
The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.
Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.
* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.
For more information, please visit: http://www.vigconic.com
Or, contact:
William Yip cs@vigconic.com
5/F, Cheung Wah Building, Sheung Heung Rd,
Kowloon, Hong Kong
Tel: 852-27656200
Fax: 852-27645314
Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China
Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis C is (Hep C Chronic Fatigue)
Ways You Can Get Infected With Hepatitis C
(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:
(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:
Sharing needles, straws, pipes, spoons and other drug-related equipment.
(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus)
Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques
Being born to a mother with hepatitis C
Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.)
People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.
It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.
If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.
About The Author
News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.
News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.
Monday, December 12, 2005
Hepatitis C Complete health information regarding HCV on MedicineNet.com (Hep C Chronic Fatigue)
Hepatitis C Complete health information regarding HCV on MedicineNet.com
Learn and become aware of Hepatitis C includes a complete description of the virus, transmission, prevention, symptoms, diagnosis, and forms of treatment. ... MedicineNet Home > Diseases & Conditions A-Z List > Hepatitis C Home Page > Hepatitis C ... What is the scope of the hepatitis C problem? What is the nature (biology) of the ...
WebMD: Hepatitis C Topic Overview
What is hepatitis C and what causes it? Hepatitis C is a liver disease caused by infection with the hepatitis C virus. It is the most common blood-borne infection in the United States, affecting at...
Hepatitis C Top Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines for chronic hepatitis B. ... and Canadian rights to the hepatitis C drug consensus interferon (aka interferon alfacon ... and Ribavirin in Nonresponders with Chronic Hepatitis C. Consensus interferon/CIFN (Infergen ...
VIRAL HEPATITIS C (Hep C Chronic Fatigue)
VIRAL HEPATITIS C
VIRAL HEPATITIS C. GENERAL INFORMATION:. What is hepatitis C? To help with this plan, you must learn about viral hepatitis C. You can then discuss
eMedicine - Hepatitis, Viral : Article by David C Wolf, MD, FACP, FACG
Poynard T, Leroy V, Cohard M, et al: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Viral Hepatitis C
Should You Be Tested For Hepatitis C? A screening questionnaire for (Hep C Chronic Fatigue)
Should You Be Tested For Hepatitis C? A screening questionnaire for
for adults. By answering the questions, you may know if you should be tested for hepatitis C. Home page Should You Be Tested For Hepatitis C? A screening questionnaire for adults For
Hepatitis C - MayoClinic.com
Hepatitis C is a highly infectious disease that's usually contracted from contaminated blood. Hepatitis C ARTICLE SECTIONS Overview Signs and symptoms Causes Risk factors When to seek medical advice
Sunday, December 11, 2005
Hepatitis C: Index | CDC Viral Hepatitis (Hep C Chronic Fatigue)
Hepatitis C: Index | CDC Viral Hepatitis
Living with Chronic Hepatitis C English Language version Spanish Language version Russian
HEP C MATCH: hepatitis c information, hep c chat, liver specialists
CHRONIC HEPATITIS C INFORMATION, SYMPTOMS, TREATMENT, NEWS and more WHAT ARE THE SYMPTOMS OF HEPATITIS C? WHO SHOULD BE TESTED FOR HEP
Hepatitis C: Current Treatment
the treatment of adults with chronic hepatitis C as single agents. The recommended dose of interferons alfa-2b and alpha-2a for the treatment of chronic hepatitis C is 3,000,000 units three times a
Chronic Hepatitis C: Current Disease Management
Chronic Hepatitis C Introduction Risk Factors and Transmission Clinical Symptoms and Signs Serologic Tests Liver Biopsy Immunostaining Diagnosis Treatment Treatment Algorithm The Future of Hepatitis C
Body Weight Correlates with Hepatocellular Cancer: Presented at AASLD (Hep C Chronic Fatigue)
Body Weight Correlates with Hepatocellular Cancer: Presented at AASLD
Doctors Guide - Previous studies have shown that obesity is a risk factor for hepatocellular carcinoma (HCC), he said in his presentation on November 13th. Dr. Body weight appears to influence the course of hepatitis C infection, with lower body weight being protective against
Peregrine Pharmaceuticals, Inc. (PPHM) Names Leading Viral Experts To Its Scientific Resource Board
BioSpace - I clinical trial for the treatment of chronic hepatitis C infection (HCV) and is being studied preclinically for use
ADHS Hepatitis C Program: Chronic Hepatitis C Statistics (Hep C Chronic Fatigue)
ADHS Hepatitis C Program: Chronic Hepatitis C Statistics
Office of Infectious Disease Services Chronic Hepatitis C Statistics A registry of Hepatitis C infection was initiated in 1998. Reporting by physicians and clinical laboratories began in April
eMedicine
Hepatitis C Feature Series Newsletters Diagnosis and Treatment of Chronic Hepatitis C Infection (Series 2, Issue 5) Sign up for FREE eMedicine Hepatitis C Feature Series newsletters today! Please enter
Hepatitis C Links
- Chronic Hepatitis C
- Cirrhosis
- HCV
- Hep C
- About Hepatitis C
- Hep C Treatment
- Hep C Virus
- Hepatitis C
- Hepatitis C Awareness
- Hepatitis C Combination Therapy
- Hepatitis C Facts
- Hepatitis C Information
- Hepatitis C Therapy
- Hepatitis C Treatment
- Hepatitis C Treatment Alternatives
- Hepatitis C Treatment Options
- Hepatitis C Virus
- Liver Disease
- Viral Hepatitis
Hep C Previous Posts
- Infectious Mononucleosis (Hep C Chronic Fatigue)
- Feedster (Hep C Chronic Fatigue)
- HIV In Injecting Drug Users Reaches Highest Levels For A Decade, UK (Hep C Chronic Fatigue)
- Doctor: Getting the Most from Your Doctor s Appointment (Hep C Chronic Fatigue)
- Medscape Resource Center - Hepatitis C (Hep C Chronic Fatigue)
- Daily Planner: Monday (Hep C Chronic Fatigue)
- Treating Chronic Mutational Hepatitis B with Chinese Medicine (Hep C Chronic Fatigue)
- Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate (Hep C Chronic Fatigue)
- Valeant says Viramidine did not meet efficacy goal (Hep C Chronic Fatigue)
- Hep C - Sexual-teens.com (Hep C Chronic Fatigue)
Hepatitis C Archives
- 2005-11-20
- 2005-11-27
- 2005-12-04
- 2005-12-11
- 2005-12-18
- 2005-12-25
- 2006-01-01
- 2006-01-08
- 2006-01-15
- 2006-01-22
- 2006-01-29
- 2006-02-05
- 2006-02-12
- 2006-02-19
- 2006-02-26
- 2006-03-12
- 2006-03-19
- 2006-03-26
